Clinical Trial Update: Reducing Innate Inflammation in New Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining strategies to reduce innate inflammation in individuals with new-onset type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Type 1 Diabetes, type1diabetes | Phase 2 | Status: ACTIVE_NOT_RECRUITING